Better Pharma Dividend Stock: Novartis vs. Merck
The pharmaceutical industry is a good place to look for solid dividend stocks. Since they offer lifesaving therapies,…
Better Pharma Dividend Stock: Novartis vs. Merck
Key Points Merck’s outlook is bright despite challenges to its core franchises. Novartis is performing well despite a…
Merck’s $6.7B Terns Acquisition Positions It to Challenge a Blockbuster Novartis Cancer Drug
Merck is picking up a big new piece for its cancer drug pipeline with a $6.7 billion deal…